medigraphic.com
ISSN 2078-7170 (Electronic)

2021, Number 4

<< Back Next >>

CorSalud 2021; 13 (4)

Estimation of predictive factors for the diagnosis of cardiovascular reactivity in pregnant women

Fuentes DZ, Rodríguez SO, Castillo FF, Amador AL

Language: Spanish
References: 14
Page: 402-407
PDF size: 251.34 Kb.


ABSTRACT

Introduction: Pre-eclampsia is a progressive, multisystemic condition character-ized by an abnormal vascular response with increased systemic vascular re-sistance, endothelial dysfunction and platelet aggregation.
Objective: To assess predictive factors of vascular reactivity in women with hy-pertensive disorder of pregnancy.
Method: An analytical observational study was carried out with 80 pregnant women, selected from a study’s population of 203, with a diagnosis of hypertensive dis-order in the 34th week of pregnancy at the Hospital Universitario Ana Betancourt de Mora from Camagüey province, Cuba, between March 2018 to March 2019.
Results: Out of the 80 obstetric patients studied in a one-year period, 27 were hy-perreactive (33.7%) and more than half were normoreactive (66.3%). The ROC curve threshold value of 0.503 produced a 29.8% of false positives and an 84.2% of true positives.
Conclusions: More than half of the obstetric patients were diagnosed as normore-active and one third had cardiovascular hyperreactivity. A positive result of the sustained weight test, cardiovascular reactivity index of blood pressure, P wave dispersion and the presence of chronic high blood pressure, pre-eclampsia, over-weight and gestational diabetes were predictive factors of this cardiovascular hy-perreactivity.


REFERENCES

  1. Semper González AI, Segredo Pérez AM, Hernán-dez Narino A. Calidad de la atención a la morbili-dad materna extremadamente grave. Estudio pre-liminar. Hospital Ginecobstétrico Provincial. Ma-tanzas 2016. Rev Med Electrón. [Internet]. 2017 [citado 14 Ene 2021];39(1):53-60. Disponible en: http://www. revmedicaelectronica. sld. cu/index. php/rme/article/view/1928/pdf_199

  2. Redman CW. Fetal outcome in trial of antihyper-tensive treatment in pregnancy. Lancet. 1976; 2(7989):753-6. [DOI]

  3. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during preg-nancy: the effects of specific treatment on the growth and development of the children. Lancet. 1982;1(8273):647-9. [DOI]

  4. Majahalme S, Turjanmaa V, Tuomisto M, Lu H, Uusitalo A. Blood pressure responses to exercise as predictors of blood pressure level after 5 years. Am J Hypertens. 1997;10(1):106-16. [DOI]

  5. Falkner B. The role of cardiovascular reactivity as a mediator of hypertension in African Americans. Semin Nephrol. 1996;16(2):117-25.

  6. Regitz-Zagrosek V, Roos-Hesselink JW, Bauer-sachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. Guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo. Rev Esp Cardiol. 2019;72(2):161. e1-e161. [DOI]

  7. Hypertension in pregnancy. Report of the Ameri-can College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-31. [DOI]

  8. Torres-Leyva M, Carrazana-Escalona R, Ormigó-Polo LE, Ricardo-Ferro BT, López-Galán E, Ortiz-Alcolea L, et al. Respuesta autonómica cardio-vascular durante la prueba isométrica cubana del peso sostenido. CorSalud [Internet]. 2019 [citado 11 Feb 2021];11(1):1-10. Disponible en: http://www. revcorsalud. sld. cu/index. php/cors/article/view/342/812

  9. Chávez E, González E, Llanes MC, Garí M, García Y, García Sáez J. Relación entre la dispersión de la onda P, el índice de masa ventricular izquierda y la tensión arterial. Arch Argent Pediatr. 2013; 111(3):206-12. [DOI]

  10. Ministerio de Salud Pública. Protocolos de Aten-ción para Obstetricia y Ginecología. Vol I. 1ª Ed. Santo Domingo: Ministerio de Salud Pública [In-ternet]; 2016 [citado 17 Feb 2021]. Disponible en: https://repositorio. msp. gob. do/bitstream/handle/123456789/90/Protocolosobtetriciayginecologia. pdf?sequence=1&isAllowed=y

  11. Pérez Caballero MD, León Álvarez JL, Dueñas He-rrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hiper-tensión arterial. Rev Cuban Med [Internet]. 2017 [citado 28 Feb 2021];56(4):242-321. Disponible en: http://scielo. sld. cu/pdf/med/v56n4/med01417. pdf

  12. Zambrana RE, López L, Dinwiddie GY, Ray RM, Phillips LS, Trevisan M, Wassertheil-Smoller S. Prevalence and incident prehypertension and hy-pertension in postmenopausal Hispanic women: results from the Women's Health Initiative. Am J Hypertens. 2014;27(3):372-81. [DOI]

  13. Martínez Schulte A. Tabaquismo, alcoholismo y drogadicción en el embarazo. Gineco FLASOG [Internet]. 2019 [citado 12 Mar 2021];11:11-27. Disponible en: https://iddeasmkt. com/flasog/wp-content/uploads/2020/12/REVISTA-FLASOG-NO11_compressed. pdf

  14. Smith H, Ameh C, Roos N, Mathai M, Broek NVD. Implementing maternal death surveillance and response: A review of lessons from country case studies. BMC Pregnancy Childbirth [Internet]. 2017 [citado 12 Mar 2021];17(1):233. Disponible en: https://doi. org/10. 1186/s12884-017-1405-6




2020     |     www.medigraphic.com